Works matching IS 14642662 AND DT 2024 AND VI 25 AND IP 3
Results: 14
Issue Information.
- Published in:
- HIV Medicine, 2024, v. 25, n. 3, p. 1, doi. 10.1111/hiv.13664
- Publication type:
- Article
British HIV Association guidelines on the management of opportunistic infection in people living with HIV: Considerations in pregnancy 2024.
- Published in:
- HIV Medicine, 2024, v. 25, n. 3, p. 3, doi. 10.1111/hiv.13645
- By:
- Publication type:
- Article
Guidelines and practice of breastfeeding in women living with HIV—Results from the European INSURE survey.
- Published in:
- HIV Medicine, 2024, v. 25, n. 3, p. 391, doi. 10.1111/hiv.13583
- By:
- Publication type:
- Article
Are glucagon‐like peptide 1 receptor agonists effective in decreasing body weight and body mass index in people living with diabetes and HIV?
- Published in:
- HIV Medicine, 2024, v. 25, n. 3, p. 404, doi. 10.1111/hiv.13587
- By:
- Publication type:
- Article
Propositive follow‐up: Long‐term immune responses to the 4CMenB and MenACWY vaccines in people living with HIV.
- Published in:
- HIV Medicine, 2024, v. 25, n. 3, p. 370, doi. 10.1111/hiv.13586
- By:
- Publication type:
- Article
Clinical significance and management of low‐level HIV viremia in the era of integrase strand transfer inhibitors.
- Published in:
- HIV Medicine, 2024, v. 25, n. 3, p. 361, doi. 10.1111/hiv.13585
- By:
- Publication type:
- Article
Comorbidity of Myasthenia gravis and Graves' disease as immune reconstitution‐associated autoimmune disease in HIV infection: A case report and literature review.
- Published in:
- HIV Medicine, 2024, v. 25, n. 3, p. 398, doi. 10.1111/hiv.13584
- By:
- Publication type:
- Article
Asian participants' experience in phase 3/3b studies of long‐acting cabotegravir and rilpivirine: Efficacy, safety, pharmacokinetic, and virological outcomes through week 96.
- Published in:
- HIV Medicine, 2024, v. 25, n. 3, p. 381, doi. 10.1111/hiv.13588
- By:
- Publication type:
- Article
Hepatitis delta in HIV/hepatitis B coinfection: A call for action.
- Published in:
- HIV Medicine, 2024, v. 25, n. 3, p. 319, doi. 10.1111/hiv.13581
- By:
- Publication type:
- Article
HIV pre‐exposure prophylaxis services, provision, and delivery in the European treatment network of HIV, hepatitis and global emerging infectious diseases (NEAT ID).
- Published in:
- HIV Medicine, 2024, v. 25, n. 3, p. 353, doi. 10.1111/hiv.13580
- By:
- Publication type:
- Article
HIV disease metrics and COVID‐19 infection severity and outcomes in people living with HIV in central and eastern Europe.
- Published in:
- HIV Medicine, 2024, v. 25, n. 3, p. 343, doi. 10.1111/hiv.13578
- By:
- Publication type:
- Article
Effects of a hospital discharge clinic among people with HIV: Lack of early follow‐up is associated with 30‐day hospital readmission and decreased retention in care.
- Published in:
- HIV Medicine, 2024, v. 25, n. 3, p. 332, doi. 10.1111/hiv.13577
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- HIV Medicine, 2024, v. 25, n. 3, p. 317, doi. 10.1111/hiv.13504
- Publication type:
- Article
HIV cure: Are we going to make history?
- Published in:
- HIV Medicine, 2024, v. 25, n. 3, p. 322, doi. 10.1111/hiv.13557
- By:
- Publication type:
- Article